NEWS: 公告在东京证券交易所JASDAQ标准市场新上市

表纸
市场调查报告书

胃肠消化健康市场

Gastrointestinals & Health Through Digestion

出版商 Nicholas Hall & Company 商品编码 971226
出版日期 内容资讯 英文
订单完成后即时交付
价格
胃肠消化健康市场 Gastrointestinals & Health Through Digestion
出版日期: 2021年02月01日内容资讯: 英文
简介

截至2020年中的12个月中,全球胃肠道和益生菌市场增长了3.6%,达到约220亿美元。到2029年,市场规模预计将超过330亿美元。这是由于现代生活方式(通常以不规则和不健康的饮食习惯和增加的酒精摄入为特征),消费者对消化状态,主要的发射活动和益生菌的瞭解增加,受到健康益处和广泛接受的推动。

但是,每个市场和类别中的成分限制,与自有品牌和仿制药的竞争以及某些成熟类别中缺乏创新是市场上的一些限制。

另一方面,消化健康是消费者保健中最热门的话题之一。肠道菌群对于维持人体的自然防御能力和改善整体健康至关重要。许多产品(主要是益生菌,益生元和合生元)提供了与消化有关的肠道健康相关益处,例如免疫力,体重管理,情绪和压力以及皮肤健康。此外,正在进行的肠脑轴研究为肠道菌群在健康中的作用日益扩大提供了新的思路。

本报告调查了胃肠道和消化健康市场,包括市场规模和趋势,销售预测,增长因素,法规,顶线销售,品牌绩效,新开发/发布,竞争状况,主要内容,提供公司等信息。个人资料。

目录

执行摘要

  • 世界概况
  • 竞争形势
  • 类别评论
  • 消化系统健康
  • 展望

巴西

  • 概述
  • 抗酸剂
  • 防胀气
  • 泻药
  • 止泻药
  • 消化□
  • 肝脏和胆汁的治疗
  • 解痉药和IBS治疗
  • 其他地理标志
  • 益生菌
  • 展望

中国

法国

德国

印度

意大利

日本

墨西哥

俄罗斯

美国

每个市场概述

  • 加拿大
  • 波兰
  • 韩国
  • 英国

品牌案例研究

  • Biostime
  • Dulcolax
  • Gaviscon
  • Pedialyte
  • Tums

展望与预测

目录

Gastrointestinals, Probiotics & the Evolving Market for Health Through Digestion

KEY FEATURES OF THIS REPORT:

  • An in-depth exploration of the GIs and Probiotics market globally, including Antacids, Laxatives, Antidiarrhoeals, Liver & bile remedies, Digestive enzymes, Probiotics and more
  • Coverage of 10 major markets from around the world, with topline sales, brand performances, new developments, launches and promotional campaigns PLUS mini-profiles of additional markets
  • Very latest mid-year 2020 sales from DB6 , our dedicated CHC sales database, plus historical growth rates back to 2015
  • Case studies of key brands , highlighting strategies and success factors, sales, NPD activity and consumer & HCP promotion
  • Forecast sales to 2020 & 2021 for all categories and countries, plus longer-term predictions to 2024 & 2029

The global market for Gastrointestinals plus Probiotics expanded by 3.6% in the 12 months to mid-2020 to nearly $22bn; it is set to be worth over $33bn by 2029. It is being driven by modern lifestyles (often characterised by irregular unhealthy eating patterns and increased alcohol intake), rising consumer understanding of digestive conditions, limited but important launch activity, and wider acceptance of the health benefits of probiotics. Holding back growth are ingredient restrictions in selected markets and categories, brands facing competition from private labels & generics, and a lack of innovation in certain mature categories.

Health Through Digestion is one of the hottest topics in consumer healthcare. The gut microbiome is of central importance in maintaining the body's natural defences and boosting overall wellness. A host of products, primarily probiotics, prebiotics and synbiotics, offer gut health-related benefits beyond digestion such as immunity, weight management, mood & stress, skin health, and more. Ongoing research into the gut-brain axis (the biochemical signal between GI tract and central nervous system) casts fresh light on the expanding role of gut flora in health.

Key questions investigated in this report:

  • How do markets differ in terms of growth drivers, regulations and competitive landscape?
  • Which marketers and brands are performing best and what can be learned from their success?
  • What are the best examples of recent NPD and which developments will help expand the market in future?
  • How have sales been affected by the Covid-19 pandemic?
  • What are the latest findings related to Health through digestion?
  • Do gaps in the market still exist and who is best placed to seize future opportunities?

Covering all the issues affecting the GIs and Probiotics market, from consumer trends and regulatory changes to A+P campaigns and new product launch activity, this report spans 10 in-depth country profiles (generating over 70% of global sales between them) with insights and predictions, plus mini-profiles of additional markets .

New product developments are explored across markets, including Rx-to-OTC switches, delivery format innovations, line extensions, new benefits and more.

As part of the global overview, this report digs into the latest trends & developments in Health through digestion , including food intolerance and adult & infant nutrition.

Categories covered in this report:

  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Digestive enzymes
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Traditional digestive remedies
  • Other GIs
  • Probiotics

selected markets only.

Brand case studies evaluate the key lessons to be learned from top brands, including consumer messaging, line extensions, portfolio development and brand strategies.

The report features the latest sales data from our dedicated DB6 database, including topline historical sales by region, country and category, and individual brand performances. Sales cover 12 months to mid-year 2020 (and mid-2019), plus historical growth rates back to 2015. The latest short-term forecasts to 2020 & 2021 and longer-term forecasts to 2024 & 2029 for each market and category are included.

Segmentation of sales in selected categories, including antacids, laxatives and probiotics, helps give a more detailed picture of each market.

10 individual markets covered:

  • Brazil
  • China
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Mexico
  • Russia
  • USA

PLUS coverage of selected additional markets in brief.

Table of Contents

Executive Summary

  • Global overview
  • Competitive landscape
  • Category review
  • Health through digestion
  • Outlook

Brazil

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Digestive enzymes
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Other GIs
  • Probiotics
  • Outlook

China

  • Overview
  • Antacids
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Digestive enzymes
  • Liver & bile remedies
  • Other GIs
  • Probiotics
  • Outlook

France

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Other GIs
  • Probiotics
  • Outlook

Germany

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Digestive enzymes
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Other GIs
  • Probiotics
  • Outlook

India

  • Overview
  • Antacids
  • Laxatives
  • Antidiarrhoeals
  • Liver & bile remedies
  • Traditional digestive remedies
  • Probiotics
  • Outlook

Italy

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Probiotics
  • Outlook

Japan

  • Overview
  • Antacids
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Antispasmodics & IBS remedies
  • Traditional digestive remedies
  • Probiotics
  • Outlook

Mexico

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Digestive enzymes
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Other GIs
  • Probiotics
  • Outlook

Russia

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Digestive enzymes
  • Liver & bile remedies
  • Antispasmodics & IBS remedies
  • Other GIs
  • Probiotics
  • Outlook

USA

  • Overview
  • Antacids
  • Antiflatulents
  • Laxatives
  • Antidiarrhoeals
  • Antinauseants
  • Digestive enzymes
  • Liver & bile remedies
  • Other GIs
  • Probiotics
  • Outlook

Selected markets in brief

  • Canada
  • Poland
  • South Korea
  • UK

Brand Case Studies

  • Biostime
  • Dulcolax
  • Gaviscon
  • Pedialyte
  • Tums

Outlook & Prospects